It should be noted that the “proliferative stem cells” defined in this study are a population selected based on high expression of broad proliferation-related markers (MKI67 and STMN1), and actually comprise a mixture of cell subtypes with high proliferative activity, rather than strictly corresponding to classical definitions of cancer stem cells or mesenchymal stem cells. The gene discussed is STMN1; the disease is cancer.